Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis.
Inflammatory bowel disease (IBD)
Mayo endoscopic score (MES)
Mucosal healing (MH)
Steroid-free clinical remission
Ulcerative colitis (UC)
Journal
BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547
Informations de publication
Date de publication:
03 Mar 2022
03 Mar 2022
Historique:
received:
18
09
2021
accepted:
10
02
2022
entrez:
4
3
2022
pubmed:
5
3
2022
medline:
8
3
2022
Statut:
epublish
Résumé
Mucosal healing (MH) evaluated by endoscopy is a novel target of therapy in UC as it is associated with improved long-term outcomes. It is defined based on the Mayo endoscopic score (MES), but it is still to define whether a value of MES 0 or 1 should be the target. The purpose of this paper is to present the results of a systematic review with meta-analysis which compares long-term outcomes of patients in steroid-free clinical remission with MES 0 with those with MES 1. A systematic electronic search of the literature was performed using Medline, Scopus, and CENTRAL through December 2020 (PROSPERO n:CRD42020179333). The studies concerned UC patients, in steroid-free clinical remission, with MES of 0 or 1, and with at least 12-months of follow-up. Out of 4611 citations, 15 eligible studies were identified. Increases in clinical relapse among patients with MES 1 were observed in all the studies included in this review, suggesting that MES of 1 have a higher risk of relapse than a score of 0. MES 0 patients displayed a lower risk of clinical relapse (OR 0.33; 95% CI 0.26-0.43; I MES 0 is associated with a lower rate of clinical relapse than is MES 1. For this reason, MES 0, rather than MES 0-1, should be considered the therapeutic target for patients with UC.
Sections du résumé
BACKGROUND
BACKGROUND
Mucosal healing (MH) evaluated by endoscopy is a novel target of therapy in UC as it is associated with improved long-term outcomes. It is defined based on the Mayo endoscopic score (MES), but it is still to define whether a value of MES 0 or 1 should be the target. The purpose of this paper is to present the results of a systematic review with meta-analysis which compares long-term outcomes of patients in steroid-free clinical remission with MES 0 with those with MES 1.
METHODS
METHODS
A systematic electronic search of the literature was performed using Medline, Scopus, and CENTRAL through December 2020 (PROSPERO n:CRD42020179333). The studies concerned UC patients, in steroid-free clinical remission, with MES of 0 or 1, and with at least 12-months of follow-up.
RESULTS
RESULTS
Out of 4611 citations, 15 eligible studies were identified. Increases in clinical relapse among patients with MES 1 were observed in all the studies included in this review, suggesting that MES of 1 have a higher risk of relapse than a score of 0. MES 0 patients displayed a lower risk of clinical relapse (OR 0.33; 95% CI 0.26-0.43; I
CONCLUSIONS
CONCLUSIONS
MES 0 is associated with a lower rate of clinical relapse than is MES 1. For this reason, MES 0, rather than MES 0-1, should be considered the therapeutic target for patients with UC.
Identifiants
pubmed: 35240984
doi: 10.1186/s12876-022-02157-5
pii: 10.1186/s12876-022-02157-5
pmc: PMC8895505
doi:
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
92Informations de copyright
© 2022. The Author(s).
Références
Inflamm Bowel Dis. 2014 Feb;20(2):231-9
pubmed: 24351660
Aliment Pharmacol Ther. 2011 Jul;34(2):113-24
pubmed: 21615435
Am J Gastroenterol. 2019 Dec;114(12):1922-1923
pubmed: 31658106
Clin Gastroenterol Hepatol. 2016 Sep;14(9):1245-1255.e8
pubmed: 26829025
Am J Gastroenterol. 2015 Sep;110(9):1324-38
pubmed: 26303131
J Crohns Colitis. 2017 Jul 1;11(7):769-784
pubmed: 28513805
Endosc Int Open. 2019 Apr;7(4):E568-E575
pubmed: 30957007
Inflamm Bowel Dis. 2021 Jan 19;27(2):207-214
pubmed: 32170946
J Am Med Assoc. 1951 Oct 6;147(6):541-9
pubmed: 14873501
J Crohns Colitis. 2016 Jan;10(1):13-9
pubmed: 26351390
Lancet Gastroenterol Hepatol. 2021 Feb;6(2):139-148
pubmed: 33189181
Gastroenterology. 2004 Feb;126(2):451-9
pubmed: 14762782
Am J Gastroenterol. 2019 May;114(5):733-745
pubmed: 30694863
World J Gastroenterol. 2013 Feb 21;19(7):968-78
pubmed: 23467585
Gastrointest Endosc. 2018 Dec;88(6):887-898
pubmed: 30142351
Cochrane Database Syst Rev. 2018 Jan 16;1:CD011450
pubmed: 29338066
Inflamm Bowel Dis. 2017 Dec;23(12):2238-2244
pubmed: 28991857
Scand J Gastroenterol. 2016 Sep;51(9):1069-74
pubmed: 26895215
Intest Res. 2016 Jan;14(1):37-42
pubmed: 26884733
Eur J Intern Med. 2011 Dec;22(6):621-5
pubmed: 22075292
Gastroenterology. 2020 Oct;159(4):1262-1275.e7
pubmed: 32585306
Dig Dis Sci. 1994 Jul;39(7):1550-7
pubmed: 8026269
Therap Adv Gastroenterol. 2017 Oct;10(10):749-759
pubmed: 29051786
Expert Rev Gastroenterol Hepatol. 2014 Feb;8(2):139-45
pubmed: 24417262
J Crohns Colitis. 2016 Jan;10(1):20-5
pubmed: 26438714
Am J Gastroenterol. 2016 Dec;111(12):1692-1701
pubmed: 27725645
J Crohns Colitis. 2017 Jun 1;11(6):649-670
pubmed: 28158501
Intest Res. 2018 Jan;16(1):55-61
pubmed: 29422798
Am J Gastroenterol. 2019 Mar;114(3):384-413
pubmed: 30840605
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
Gut. 2019 Dec;68(Suppl 3):s1-s106
pubmed: 31562236
Aliment Pharmacol Ther. 2010 Oct;32(8):984-9
pubmed: 20937043
Gastroenterology. 2021 Apr;160(5):1558-1569.e8
pubmed: 33347880
J Clin Epidemiol. 2001 Oct;54(10):1046-55
pubmed: 11576817
Radiology. 1951 Jul;57(1):1-14
pubmed: 14854178
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
United European Gastroenterol J. 2018 Jun;6(5):765-772
pubmed: 30083339
Dig Liver Dis. 2017 Dec;49(12):1327-1331
pubmed: 28958412
Gut. 2016 Mar;65(3):408-14
pubmed: 25986946
Dig Liver Dis. 2013 Dec;45(12):969-77
pubmed: 23932331
Expert Rev Gastroenterol Hepatol. 2016 Aug;10(8):915-27
pubmed: 27043489
J Crohns Colitis. 2019 Mar 26;13(3):273-284
pubmed: 30137278
Gastroenterol Res Pract. 2013;2013:192794
pubmed: 23762033
Expert Rev Gastroenterol Hepatol. 2014 Jul;8(5):457-9
pubmed: 24654957
Clin Transl Gastroenterol. 2018 Feb 20;9(3):136
pubmed: 29491393
J Dig Dis. 2017 Nov;18(11):634-641
pubmed: 28949435